2023 Partners
Curebase is a leading provider of decentralized clinical research software and services for digital therapeutics. Curebase enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform, virtual research site, and full-service CRO.
Learn More
Decimal.health is a specialized digital health consulting firm that creates and implements
strategies to launch and grow digital health products and services. Through our deep network
and expertise in US healthcare delivery and regulations, we help digital health businesses
navigate the complex DTx and FDA regulatory path and gain traction with investors and
customers
Learn More
Ieso is a data-driven AI healthcare company pioneering next-generation digital therapeutics to improve mental health outcomes and access to care.
The company is developing a pipeline of AI-driven evidence-based mental health assessment tools and solutions to democratize access to mental health therapy at scale. With a network of more than 600 fully qualified therapists, ieso provides virtual care (or telehealth) serving more than 20 million adults through the UK National Health Service (NHS), delivering more than 460,000 hours of cognitive behavioral therapy (CBT).
The company has analyzed over 500 million datapoints to decode the active ingredients of therapy to develop scalable digital therapeutics. ieso’s research has been published in several peer-reviewed journals including the Lancet and JAMA, shaping our understanding of scalable digital mental healthcare solutions.
Learn More
DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization
We specialize in go-to-market strategy development:
– Market Access and Reimbursement
– Business models development
– Data monetization
Our Payer Advisory Council provides actionable insight
Custom qualitative research
– One-one-one interviews
Advisory board meetings
– Virtual
– Live face-to-face meetings
Learn More
DTx West has returned! Bringing you 3 full days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. Come along to DTx West 2023 and get exclusive access to the latest and greatest in digital medicine. We look forward to seeing you in February!
The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Step away from the screen for 3 days of industry-defining discussions and catch up with old and make new connections within the field. Gone are the days where we are networking from our computers. At DTx West 2023 come face to face with the who’s who in digital healthcare as we tackle the leading questions facing the industry today.
Experts from every stakeholder within the digital therapeutics space will be coming down to California in February 2023. Calling to every corner of the industry, join your peers from leading DTx companies, Pharma, Payers, Providers, Government Bodies, Academia, Policy Makers and more!
“The digital therapeutics industry as a whole is incredibly collaborative, and the DTx conference series provides the ideal platform for all stakeholders to come together, share ideas, and leave with the ability to have the most impact on patients’ lives”
“DTx East was by far the best digital conference I’ve been to”
“DTx conferences are excellent places to collaborate with top leaders and stay current on the often complex and evolving trends shaping our investments – all while being part of a passionate, growing community of entrepreneurs.”
2023 Speaker Faculty
Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.
Dr. Robinson leads Moffitt’s Center for Digital Health which
leverages the tools of IT, Health Data Services, and Digital
Innovation to expand Moffitt’s ecosystem to deliver on consumer-
oriented, real-world solutions for clinical practice, research,
education, and administrative processes. The Center for Digital
Health creates and tests new services, programs, partnerships, and
technologies that leverage digital innovations, while challenging the
status quo to reduce the cost of care, improve quality, increase
access to care, and enhance the patient experience. In addition, he
directly cares for Moffitt patients as part of the Internal and Hospital
Medicine Program.
Previously, Dr. Robinson was the Chief Transformation Officer and
Senior Vice President of Consumerism at ChristianaCare, one of the
largest health systems in the mid-Atlantic. He was responsible for
the transformation of health care delivery to advance population
health initiatives and the move from volume-based to value-based
care with a special focus on developing and managing
ChristianaCare’s consumerism and digital strategies.
Dr. Robinson is an associate professor at University of South
Florida’s Morsani College of Medicine. He is also a fellow of the
American College of Physicians and a senior fellow of the Society of
Hospital Medicine. He holds a medical degree from the David
Geffen School of Medicine at the University of California, Los
Angeles; an MBA with an emphasis in health care management from
the Wharton School at the University of Pennsylvania; and a
master’s degree in health policy research also from the University of
Pennsylvania.
Sara Sarkey is the VP, US Medical Head for Neuroscience and Vaccines at Takeda Pharmaceuticals. Her
dedicated Medical team seeks to better understand and communicate the real-world effects of Takeda’s
medications as well as partner with other groups within the healthcare system to bring innovative,
patient-focused solutions to the treatment of diseases within the Neuroscience and Vaccines space.
Prior to joining Takeda Pharmaceuticals, Sara was in academic research at Loyola University Chicago,
focused primarily on the impacts of hormonal regulation on the developing brain. She is also President
of the Board at Erasing the Distance, a nonprofit organization based in Chicago dedicated to
empowering people with mental illness and reducing stigma through personal storytelling. Sara
currently lives in the Boston area with her husband and 2 sons.
Location
The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Catch up with familiar faces and make new connections within the field.
We will be coming together in Bay Area, CA.
Our venue will be announced soon!
Partner with us
The DTx summits are the premier events for senior executives from DTx companies, Pharma, Policy Makers, Investors, HCPs and Payers.
DTx West 2023 is the twelth summit in the US DTx series. We anticipate over 450 people in attendance, which is what our attendees and partners tell us is the optimum size.
We believe that getting the right mix of partners is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world-class audience.
You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.
Get in touch today to learn more and avoid missing out!
Register for the Event
For pricing and booking options please click the button to go to the registration page.